NCT02204241View on ClinicalTrials.gov

Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

April 30, 2023

Conditions
Multiple Myeloma
Interventions
DRUG

Carfilzomib

DRUG

Cyclophosphamide

DRUG

Dexamethasone

Trial Locations (1)

10126

Fondazione EMN Italy Onlus, Torino

All Listed Sponsors
collaborator

Fondazione EMN Italy Onlus

OTHER

lead

European Myeloma Network B.V.

NETWORK

NCT02204241 - Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients | Biotech Hunter | Biotech Hunter